BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8752253)

  • 1. Cost analysis of shared oocyte in vitro fertilization.
    Peskin BD; Austin C; Lisbona H; Goldfarb JM
    Obstet Gynecol; 1996 Sep; 88(3):428-30. PubMed ID: 8752253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-effectiveness comparison of embryo donation with oocyte donation.
    Finger R; Sommerfelt C; Freeman M; Wilson CK; Wade A; Daly D
    Fertil Steril; 2010 Feb; 93(2):379-81. PubMed ID: 19406398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamete intrafallopian transfer. A cost-effective alternative to donor oocyte in vitro fertilization in women aged 40-42 years.
    Silva PD; Olson KL; Meisch JK; Silva DE
    J Reprod Med; 1998 Dec; 43(12):1019-22. PubMed ID: 9883404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes of different groups of women in Sweden to oocyte donation and oocyte research.
    Westlander G; Janson PO; Tägnfors U; Bergh C
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):317-21. PubMed ID: 9539279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of assisted reproductive technologies for a health maintenance organization.
    Hidlebaugh DA; Thompson IE; Berger MJ
    J Reprod Med; 1997 Sep; 42(9):570-4. PubMed ID: 9336753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A detailed cost analysis of in vitro fertilization and intracytoplasmic sperm injection treatment.
    Bouwmans CA; Lintsen BM; Eijkemans MJ; Habbema JD; Braat DD; Hakkaart L
    Fertil Steril; 2008 Feb; 89(2):331-41. PubMed ID: 17662286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ART in women 40 and over. Is the cost worth it?
    Legro RS; Shackleford DP; Moessner JM; Gnatuk CL; Dodson WC
    J Reprod Med; 1997 Feb; 42(2):76-82. PubMed ID: 9058341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost analysis of in vitro fertilization.
    Stern Z; Laufer N; Levy R; Ben-Shushan D; Mor-Yosef S
    Isr J Med Sci; 1995 Aug; 31(8):492-6. PubMed ID: 7635699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Socioeconomic approach to the practice of in vitro fertilization in the Brittany region in 1993].
    Poulain P; Le Lannou D; Le Martelot MT; Vialard J; Chevalier R; Corvez A; Keraudren B; Taillanter L; Giraud JR
    Contracept Fertil Sex; 1995 Apr; 23(4):261-6. PubMed ID: 7757134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-saving treatment strategies in in vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha.
    Wechowski J; Connolly M; Schneider D; McEwan P; Kennedy R
    Fertil Steril; 2009 Apr; 91(4):1067-76. PubMed ID: 18339384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the cost-to-benefit ratio of in-vitro fertilization.
    Silva PD; Sorensen ML; Silva DE
    Wis Med J; 1997 Jan; 96(1):36-9. PubMed ID: 9020620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic implications of insurance coverage for in vitro fertilization in the United States. A review.
    Omurtag KR; Styer AK; Session D; Toth TL
    J Reprod Med; 2009; 54(11-12):661-8. PubMed ID: 20120898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic evaluation of oocyte donors: recipient couple preferences and outcome of testing.
    Baker VL; Rone HM; Adamson GD
    Fertil Steril; 2008 Dec; 90(6):2091-8. PubMed ID: 18249390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of in vitro fertilization.
    Collins J
    Semin Reprod Med; 2001 Sep; 19(3):279-89. PubMed ID: 11679909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint.
    Polinder S; Heijnen EM; Macklon NS; Habbema JD; Fauser BJ; Eijkemans MJ
    Hum Reprod; 2008 Feb; 23(2):316-23. PubMed ID: 18033807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstetric outcomes in donor oocyte pregnancies compared with advanced maternal age in in vitro fertilization pregnancies.
    Krieg SA; Henne MB; Westphal LM
    Fertil Steril; 2008 Jul; 90(1):65-70. PubMed ID: 17727845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partnership for Families Program: philanthropy for in vitro fertilization patients.
    Goldfarb JM; Fisher NL; Gillespie L; Austin CM; Lisbona H; Peskin BD; Desai N
    J Reprod Med; 2009 Sep; 54(9):548-52. PubMed ID: 19947031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effects of oocyte cryopreservation in assisted reproduction technology].
    Wang W; Yan ZJ; Cai LB; Chai DC; Liu CZ; Mao YD; Liu JY
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2755-8. PubMed ID: 19080449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis of singleton versus twin pregnancies after in vitro fertilization.
    Lukassen HG; Schönbeck Y; Adang EM; Braat DD; Zielhuis GA; Kremer JA
    Fertil Steril; 2004 May; 81(5):1240-6. PubMed ID: 15136084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of oocyte cryopreservation: a meta-analysis.
    Oktay K; Cil AP; Bang H
    Fertil Steril; 2006 Jul; 86(1):70-80. PubMed ID: 16818031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.